Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Cynata Therapeutics Limited
(CYYNF)
OTHER OTC
:CYYNF
CYYNF
Cynata Therapeutics Limited
Overview
Analyst Forecasts
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Cynata Therapeutics Limited (CYYNF) Stock News & Sentiment
Compare
Follow
5
Followers
Premium
Company Announcements
Cynata Narrows Half-Year Loss but Faces Going Concern Uncertainty
30d ago
Premium
Company Announcements
Cynata to Host Investor Webinar and Expand Online Engagement With Shareholders
2M ago
Premium
Company Announcements
Cynata Nears Key Data Readouts as Pivotal Cell Therapy Trials Advance
2M ago
Premium
Company Announcements
Cynata Raises $1.2m via At-The-Market Facility to Support Cell Therapy Pipeline
2M ago
Premium
Company Announcements
Cynata Completes Enrollment in Phase 2 aGvHD Trial
3M ago
Premium
Company Announcements
Cynata’s CYP-001 Therapy Shows Promise in Kidney Transplant Trial
4M ago
Premium
Company Announcements
Cynata Therapeutics Updates Director’s Securities Holdings
4M ago
More CYYNF News >
CYYNF News on the Web
All News
Bearish News
Bullish News
2026-03-26
Japan’s milestone iPSC approval puts Cynata’s platform in spotlight
StockHead
Neutral
2026-02-26
Cynata Narrows Half-Year Loss but Faces Going Concern Uncertainty
TipRanks News
Bearish
2026-02-17
Cynata has two shots on goal with pivotal trial readouts approaching
StockHead
Neutral
2026-02-17
Biocurious: from Türkiye to Tashkent, biotechs steer off the beaten track
StockHead
Bullish
2026-02-12
ASX healthcare players focusing on rare diseases as incentives stack up
StockHead
Bullish
2026-02-10
Biocurious: Without a hint of hyperbole, ASX stem-cell developers lead the way on world-first therapies
StockHead
Bullish
2026-01-29
ASX Quarterly Health Wrap: Trials advance as a major discovery lands
StockHead
Bullish
2026-01-29
Cynata Nears Key Data Readouts as Pivotal Cell Therapy Trials Advance
TipRanks News
Bullish
89
Results | Showing
1
out of
12
News Score - Last 7 Days
Neutral
CYYNF
Sector Average
Media Buzz
This Week
1 articles
Weekly Average
1 articles
News Sentiment
This Week
50%
Sector Average
68%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is CYYNF’s Media Buzz Sentiment?
1 articles about CYYNF were published this week. In an average week, 1 articles are published.
What is CYYNF’s weekly average amount of articles?
In an average week, 1 articles about CYYNF are published.
What is CYYNF’s News Sentiment?
50% of articles about CYYNF were positive this week, compared to its sector average of 68%.
Healthcare Stocks that are Trending in the News
WXIBF
Wuxi Biologics (Cayman)
KOD
Kodiak Sciences
GILD
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S
2359
WuXi AppTec Co., Ltd. Class H
RZLT
Rezolute
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.